Australian bat lyssavirus in a child: The first reported case

Pediatrics

Volumn 133, Issue 4, 2014, Pages

  Francis, Joshua R ^a   Nourse, Clare ^a,b   Vaska, Vikram L ^a,c   Calvert, Sophie ^d   Northill, Judith A ^e   McCall, Brad ^f   Mattke, Adrian C ^a  

^a MATER CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Mater Pathology ^*  (Australia)

^d Neurology Department   (Australia)

^e QUEENSLAND HEALTH   (Australia)

^f Metro South Mental Health   (Australia)

Author keywords

Australia; Bat; Child; Lyssavirus; Rabies

Indexed keywords

ACICLOVIR; AMANTADINE; ANALGESIC AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CEFOTAXIME; HYDROCORTISONE; KETAMINE; MAGNESIUM; METHYLPREDNISOLONE; OPIATE; PHENYTOIN; PROPOFOL; TETANUS ANTIBODY; TRIACYLGLYCEROL LIPASE; VANCOMYCIN; VASOPRESSIN; VIRUS ANTIBODY;

ACUTE ABDOMEN; ACUTE PANCREATITIS; ANOREXIA; ARTICLE; AUSTRALIA; AUSTRALIAN BAT LYSSAVIRUS; BACTERIAL INFECTION; BODY TEMPERATURE DISORDER; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID; CHILD; COMPRESSION THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES INSIPIDUS; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DYSAUTONOMIA; DYSPHAGIA; ENCEPHALITIC RABIES; ENDOTRACHEAL INTUBATION; EXTENSOR SPASM; EXTUBATION; FEVER; HEART ATRIUM ARRHYTHMIA; HUMAN; HYPERNATREMIA; HYPERTENSION; HYPOGLYCEMIA; INFANTILE SPASM; INTUBATION; LACTIC ACIDOSIS; MALE; MYCOSIS; MYDRIASIS; NEUROIMAGING; NEUTROPHILIA; PARALYSIS; PNEUMOMEDIASTINUM; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; RABIES; RABIES VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEDATION; SEIZURE; SERUM BACTERICIDAL ANTIBODY ASSAY; SINUS ARREST; SINUS NODE DISEASE; TACHYCARDIA; TEMPERATURE INSTABILITY; BAT; FATALITY; REVIEW; RHABDOVIRUS INFECTION;

AUSTRALIA; BAT; CHILD; LYSSAVIRUS; RABIES;

AUSTRALIA; CHILD; FATAL OUTCOME; HUMANS; LYSSAVIRUS; MALE; RHABDOVIRIDAE INFECTIONS;

EID: 84901724068     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1782     Document Type: Article

References (23)

1. Warrilow D, Harrower B, Smith IL, et al. Public health surveillance for Australian bat lyssavirus in Queensland, Australia, 2000-2001. Emerg Infect Dis. 2003;9(2):262-264
2. Samaratunga H, Searle JW, Hudson N. Nonrabies Lyssavirus human encephalitis from fruit bats: Australian bat Lyssavirus (pteropid Lyssavirus) infection. Neuropathol Appl Neurobiol. 1998;24(4):331-335
3. Hanna JN, Carney IK, Smith GA, et al. Australian bat lyssavirus infection: a second human case, with a long incubation period. Med J Aust. 2000;172(12):597-599
4. Heaton PR, Johnstone P, McElhinney LM, Cowley R, O'Sullivan E, Whitby JE. Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses. J Clin Microbiol. 1997;35(11):2762-2766
5. Smith IL, Northill JA, Harrower BJ, Smith GA. Detection of Australian bat lyssavirus using a fluorogenic probe. J Clin Virol. 2002;25(3):285-291
6. Children's Hospital of Wisconsin. Rabies registry home page. 2013; www.chw.org/rabies. Accessed April 8, 2013
7. McCall BJ, Epstein JH, Neill AS, et al. Potential exposure to Australian bat lyssavirus, Queensland, 1996-1999. Emerg Infect Dis. 2000;6(3):259-264
8. Plotkin SA. Rabies. Clin Infect Dis. 2000;30 :4-12
9. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol. 2002;1 :101-109
10. Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet. 2004;363(9413): 959-969
11. Omezzine A, Hmouda H, Jemni L. Spontaneous pneumomediastinum: an exceptional complication of rabies. Clin Infect Dis. 1994; 18(4):663-664
12. Guyatt KJ, Twin J, Davis P, et al. A molecular epidemiological study of Australian bat lyssavirus. J Gen Virol. 2003;84(pt 2):485-496
13. Dacheux L, Reynes JM, Buchy P, et al. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis. 2008;47(11):1410-1417
14. Jackson AC. Current and future approaches to the therapy of human rabies. Antiviral Res. 2013;99(1):61-67
15. Enright JB, Franti CE, Frye FL, Behymer DE. The effects of corticosteroids on rabies in mice. Can J Microbiol. 1970;16(8):667-675
16. Willoughby RE Jr. "Early death" and the contraindication of vaccine during treatment of rabies. Vaccine. 2009;27(51):7173-7177
17. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis. 2003;36(1):60-63
18. Willoughby RE Jr., Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005; 352(24):2508-2514
19. Rubin J, David D, Willoughby RE Jr., et al. Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea. Scand J Infect Dis. 2009;41(5):372-375
20. O'Sullivan A, Willoughby RE, Mishchuk D, et al. Metabolomics of cerebrospinal fluid from humans treated for rabies. J Proteome Res. 2013;12(1):481-490
21. Aramburo A, Willoughby RE, Bollen AW, et al. Failure of the Milwaukee protocol in a child with rabies. Clin Infect Dis. 2011;53 :572-574
22. Communicable Disease Network Australia. Rabies virus and other lyssavirus (including Australian Bat Lyssavirus) exposures and infections. Series of National Guidelines 2013. Available at: www.health.gov.au/internet/main/ publishing.nsf/Content/cdna-song-abvlrabies.htm. Accessed May 6, 2013
23. Manning SE, Rupprecht CE, Fishbein D, et al Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC). Human rabies prevention -United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57(RR-3):1-28